Recombinant Human RNF41 Protein ，GST

RNF41 (RING Finger Protein 41) is an E3 ubiquitin ligase that plays a pivotal role in various cellular processes, including protein degradation, signal transduction, and cell cycle regulation. Recent studies have highlighted its involvement in the modulation of immune responses and its potential as a therapeutic target in cancer treatment. Given its significant role in the ubiquitin-proteasome system, RNF41 is crucial for maintaining cellular homeostasis and influencing the stability of key regulatory proteins. The abnormal expression or dysfunction of RNF41 has been linked to various diseases, including malignancies and autoimmune disorders. As researchers strive to elucidate the molecular mechanisms underlying these associations, the recombinant production of RNF41 protein has gained attention, enabling detailed structural and functional analyses. By using advanced techniques such as CRISPR/Cas9, researchers can investigate RNF41's mechanistic pathways, its interactions with substrates, and the subsequent impact on cellular functions. Understanding RNF41's role could pave the way for novel therapeutic strategies, particularly in contexts where its regulatory functions are compromised. Thus, the characterization of RNF41 through recombinant protein expression serves as a critical foundation for subsequent investigations into its biological significance and potential clinical applications.